Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriuretic Peptide Outpatient-Tailored Chronic Heart Failure Therapy (PROTECT) Study-Reference-Cited by-同舟云学术

Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriuretic Peptide Outpatient-Tailored Chronic Heart Failure Therapy (PROTECT) Study

Published:2015-01 Issue:1 Volume:21 Page:9-15
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Gandhi Parul U.,Szymonifka Jackie,Motiwala Shweta R.,Belcher Arianna M.,Januzzi James L.,Gaggin Hanna K.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Reasons for not prescribing guideline-recommended medications to adults with heart failure;Steinman;Med Care,2013

2. Predicting adverse events during angiotensin receptor blocker treatment in heart failure: results from the HEAAL trial;Kiernan;Eur J Heart Fail,2012

3. Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program;Desai;J Am Coll Cardiol,2007

4. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD);Knight;Am Heart J,1999

5. Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS);Pitt;Circulation,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Treatment With Sacubitril/Valsartan in Japanese Patients With Chronic Heart Failure and Reduced Ejection Fraction　― Open-Label Extension of the PARALLEL-HF Study ―;Circulation Journal;2023-12-25

2. Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction;Journal of the American College of Cardiology;2019-09

3. Midrange ejection fraction as a risk factor for deterioration of cardiofunction after permanent pacemaker implantation;Journal of Interventional Cardiac Electrophysiology;2019-02-09

4. Established and Emerging Roles of Biomarkers in Heart Failure;Circulation Research;2018-08-17

5. The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study;Current Heart Failure Reports;2018-02-21